The Pan American Health Organization announced yesterday that measles is no longer eliminated in the United States. The United States, which had maintained elimination status for 25 years, now faces a resurgence that has already produced 5,412 confirmed cases and 591 hospitalizations this year, with at least 10 deaths reported by state authorities and six listed by the Centers for Disease Control and Prevention (CDC). The announcement follows a steady rise in measles cases that began earlier in the year, raising concerns about vaccine coverage and public health infrastructure.
What Happened to Measles in the U.S.?
Measles was declared eliminated in the United States in 2000 after decades of aggressive vaccination campaigns. The disease, once responsible for 3 million to 4 million cases annually before the vaccine's licensure in 1963, had become a rare occurrence. High vaccination rates and effective surveillance prevented sustained transmission, allowing infants who could not yet receive the first MMR dose at 12 to 15 months to rely on herd immunity for protection.
Current Case Numbers and Deaths
As of November 12, the CDC has reported 5,412 confirmed measles cases and 591 hospitalizations for the current year. State health departments have reported at least 10 deaths, whereas the CDC's published tally lists only six. The discrepancy highlights concerns about transparency in national reporting and underscores the seriousness of the outbreak.
Who Is Most at Risk?
Babies too young to be vaccinated, pregnant women, and individuals with weakened immune systems, including those undergoing chemotherapy, face heightened danger. Clinicians are encountering cases of measles in pregnant women and infants infected before birth, conditions that can lead to severe complications. Parents of infants must now worry that routine visits to the pediatrician or simple errands could expose their children to a preventable disease.
Why Has Vaccination Coverage Dropped?
Two doses of the MMR vaccine are approximately 97 percent effective. The decline in vaccination rates is attributed to misinformation and waning confidence in public health agencies. These trends predate the current administration, but the Health and Human Services secretary, Robert F. Kennedy Jr., bears significant responsibility for restoring trust, strengthening protections, and ensuring policy is guided by scientific evidence.
Impact of Committee Changes on Vaccine Policy
Under Kennedy, the Advisory Committee on Immunization Practices (ACIP) was entirely replaced. Alterations to the committee and its processes raise serious questions about how scientific evidence is evaluated and incorporated into national policy. Vaccine recommendations influence millions, and they must rest on rigorous scientific review, transparent decision-making, and qualified expert advice.
Measles as a Warning Sign
Measles, one of the most contagious infectious diseases known, serves as a canary in the coal mine. Its resurgence signals weaknesses in U.S. infectious disease prevention that could expose communities to other threats. Effective outbreak control requires more than a vaccine: health departments must detect cases, investigate outbreaks, trace contacts, and reach exposed individuals. Clinicians need timely guidance, laboratories require resources for testing, and communities demand accurate, trusted communication. These functions depend on coordination across federal, state, and local government and a skilled public health workforce.
Weakening of Public Health Infrastructure
Recent workforce reductions and funding cuts have weakened the capacities necessary for outbreak response. Public health systems cannot perform effectively when the people and infrastructure they rely on are undermined. Reversing the decline demands action across the public health system: federal and state leaders must communicate clearly about vaccination, counter misinformation, and protect access to immunization. Congress must provide sustained funding for health departments, laboratories, and outbreak response. The CDC and other scientific institutions must maintain independent, transparent, evidence-based decision-making. Leaders must ensure that the public health workforce has the resources and institutional support to perform its functions.
Call to Action for Policymakers
Children should not suffer from a disease that can be prevented. Families should not experience devastating and preventable loss. Parents should not have to question the protections they grew up trusting. The public health workforce should not have to fight with one hand tied behind its back to protect communities. Policymakers at every level have a responsibility to act.
About the Author
Katie D. Schenk, MSc Ph.D. is a former health scientist and senior service fellow at the Centers for Disease Control and Prevention. She edits The Public Health Workforce is Not OK newsletter and leads KDS Public Health Consulting LLC.
Background
The measles vaccine, first licensed in 1963, revolutionized child health in the United States. Prior to its introduction, measles caused an estimated 3 million to 4 million cases annually, with hundreds of deaths, tens of thousands hospitalized, and many children suffering permanent brain damage. The vaccine's widespread adoption, coupled with public health campaigns, led to the elimination of endemic transmission in 2000. Since then, the U.S. relied on high vaccination coverage to protect those who could not yet be vaccinated, such as infants younger than 12 months. The elimination status was recognized by the World Health Organization and the Pan American Health Organization as a milestone in disease control.
What Happens Next?
The resurgence of measles in the United States signals a need for renewed focus on vaccination coverage and public health infrastructure. Health departments must strengthen surveillance, outbreak investigation, and contact tracing. Laboratories require adequate funding and staffing to process samples promptly. Public health messaging must counter misinformation and build trust. Congressional action is essential to secure funding for health departments, laboratories, and workforce training. The CDC must continue to provide independent, evidence-based guidance, free from political influence. Ultimately, restoring elimination status will require coordinated efforts across all levels of government, the private sector, and communities.
Related Stories
For additional context on public health challenges in the United States, see US Officially Loses Measles Elimination Status After 25 Years and F1 Inclusion Report Shows Progress, Calls for £50m Funding.